Pharmacy World & Science

, Volume 31, Issue 3, pp 394–405 | Cite as

How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions?

  • Hanni Prihhastuti PuspitasariEmail author
  • Parisa Aslani
  • Ines Krass
Research Article


Objective To investigate and compare counselling provided by community pharmacists in Australian metropolitan and rural pharmacies. Methods Mail surveys to 650 randomly selected New South Wales (NSW) community pharmacies [385 (59%) metropolitan, 265 (41%)] rural were conducted. Main outcome measure The rates of verbal and written prescription medicine information and type of information given both for new and regular medicines were determined. The rates of verbal information were also explored by assessing how likely pharmacists were to counsel based on hypothetical cases for new prescription medicines. Results A response-rate of 42% was obtained from 116/378 (31%) metropolitan and 156/262 (60%) rural pharmacies. A higher proportion of metropolitan than rural pharmacists reported providing verbal information for more than 50% of new prescriptions (P < 0.001) and for more than 50% of regular prescriptions (P < 0.001). In contrast, a higher proportion of rural than metropolitan pharmacists reported giving out Consumer Medicine Information leaflets (CMIs) for more than 50% of new prescriptions (P = 0.007). After controlling for any identified confounders, metropolitan pharmacists were 4.6 times more likely to verbally counsel on new prescriptions and 3.1 times more likely to counsel on regular prescriptions, while rural pharmacists were 2.4 times more likely to give out CMIs for new prescriptions. Information on medicine administration was provided more frequently than information on the safety aspects of medicine, with both types of information being more frequently given for new than regular prescription medicines. There was variability in responses to hypothetical cases and not all respondents were highly likely to counsel on all new prescriptions. Conclusion Metropolitan pharmacists tended to provide verbal information, while rural pharmacists tended to give out written information. The respondents prioritised counselling on medicine administration for new prescription medicines. Not all respondents, however, were highly likely to counsel on all new prescriptions.


Australia Community pharmacy Counselling Metropolitan community pharmacy Rural community pharmacy Verbal counselling Written counselling 



The researchers wish to thank the NSW community pharmacists for participating in the study.


This study was funded by Faculty of Pharmacy, the University of Sydney, Australia.

Conflict of interests

There are no conflicts of interest to report.


  1. 1.
    Humphreys J, Hegney D, Lipscombe J, Gregory G, Chater B. Whither rural health? Reviewing a decade of progress in rural health. Aust J Rural Health. 2002;10:2–14. doi: 10.1046/j.1440-1584.2002.00435.x.PubMedCrossRefGoogle Scholar
  2. 2.
    Smith KB, Humphreys J, Wilson MGA. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health. 2006;16:56–66. doi: 10.111/j.1440-1584.2008.00953.x.CrossRefGoogle Scholar
  3. 3.
    Australian Institute of Health and Welfare. Rural, regional and remote health: indicators of health status and determinants of health. Canberra: AIHW; 2008. ISBN 978 1 74024 768 9.Google Scholar
  4. 4.
    Australian Institute of Health and Welfare. Australia’s health 2004. Canberra: AIHW; 2004. ISBN 1 74024 382 X.Google Scholar
  5. 5.
    Smith KB, Humphreys J, Lenard Y, Jones JA, Prince V, Han GS. Still the doctor—by a country mile! Preferences for health services in two country towns in north-west New South Wales. Med J Aust. 2004;181:91–5.PubMedGoogle Scholar
  6. 6.
    Watts PR, Dinger MK, Baldwin KA, Sisk RJ, Brockschmidt BA, McCubbin JE. Accessibility and perceived value of health services in five Western Illinois rural communities. J Community Health. 1999;24:147–57. doi: 10.1023/A:1018758408626.PubMedCrossRefGoogle Scholar
  7. 7.
    Dundabin J, Levitt L. Rural origin and rural medical exposure: their impact on the rural and remote medical workforce in Australia. Rural Remote Health (online). 2003 Jun 25; 3: (about 17 screens). Cited 3 June 2008.
  8. 8.
    Knapp KK, Paavola FG, Maine LL, Sorofman B, Politzer RM. Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc. 1999;39:127–35.Google Scholar
  9. 9.
    Smith T, Cooper R, Brown L, Hemmings R, Greaves J. Profile of the rural allied health workforce in Northern New South Wales and comparison with previous studies. Aust J Rural Health. 2008;16:156–63. doi: 10.1111/j.1440-1584.2008.00966.x.PubMedCrossRefGoogle Scholar
  10. 10.
    Harding A, Whitehead P, Aslani P, Chen T. Factors affecting the recruitment and retention of pharmacists to practice in rural and remote areas of New South Wales: a qualitative study. Aust J Rural Health. 2006;14:214–8. doi: 10.1111/j.1440-1584.2006.00812.x.PubMedCrossRefGoogle Scholar
  11. 11.
    Ranelli PL, Coward RT. Communication between pharmacists and patients: role of place of residence in determining the expectations of older adults. Pharmacotherapy. 1997;17:148–62.PubMedGoogle Scholar
  12. 12.
    Carter BL, Barnette J, Chrischilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274–85.PubMedGoogle Scholar
  13. 13.
    Straub LA, Straub SA. Consumer and provider evaluation of rural pharmacy services. J Rural Health. 1999;15:403–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Xu KT, Rojas-Fernandez CH. Ancillary community pharmacy services provided to older people in a largely rural and ethnically diverse region: a survey of consumers in West Texas. J Rural Health. 2003;19:79–86.PubMedCrossRefGoogle Scholar
  15. 15.
    Rogers A, Hassell K, Noyce PR, Harris J. Advice-giving in community pharmacy: variations between pharmacies in different locations. Health Place. 1998;4:365–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Pharmaceutical Society of Australia. Guidelines for pharmacists on providing medicines information to patients. In: Australian pharmaceutical formulary and handbook. 20th ed. Canberra: PSA; 2006. p. 365–8.Google Scholar
  17. 17.
    Pharmaceutical Society of Australia. Guidelines: consumer medicine information and the pharmacist. In: Australian pharmaceutical formulary and handbook. 20th ed. Canberra: PSA; 2006. p. 369–70.Google Scholar
  18. 18.
    Basheti IA, Reddel HK, Armour C, Bosnic-Anticevich SZ. Counselling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care. 2005;50:617–23.PubMedGoogle Scholar
  19. 19.
    Perri M, Kofzan J, Pritchard L, Ozburn W, Francisco G. OBRA ’90: the impact on pharmacists and patients. Am Pharm. 1995;NS35(2):24–8.PubMedGoogle Scholar
  20. 20.
    Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid recipients’ perceptions of medication counselling as required by OBRA ’90. J Am Pharm Assoc. 1998;38:333–8.Google Scholar
  21. 21.
    Livingstone CR, Pugh ALG, Winn S, Williamson VK. Developing community pharmacy services wanted by local people: information and advice about prescription medicines. Int J Pharm Pract. 1996;4:94–101.Google Scholar
  22. 22.
    Rao PSRS. Sampling methodologies: with applications. Florida: CRC Press; 2000. ISBN 1-58488-214-X.Google Scholar
  23. 23.
    Department of Local Government. Local council boundaries. Sydney: NSW Government; 2007. Cited Nov 2007.
  24. 24.
    Barnes JM, Riedlinger JE, McCloskey WW, Montagne M. Barriers to compliance with OBRA ’90 regulations in community pharmacies. Ann Pharmacother. 1996;30:1101–5.PubMedGoogle Scholar
  25. 25.
    Osman NM, Bond CM, Mackenzie J, Williams S. Asthma advice giving by community pharmacists. Int J Pharm Pract. 1999;7:12–7.Google Scholar
  26. 26.
    Pronk M, Blom L, Jonkers R, Rogers EM, Bakker A, de Blaey KJ. Patient oriented activities in Dutch community pharmacy: diffusion of innovations. Pharm World Sci. 2002;24:154–61.PubMedCrossRefGoogle Scholar
  27. 27.
    Kansanaho H, Isonen-Sjolund N, Pietila K, Airaksinen M, Isonen T. Patient counselling profile in a Finnish pharmacy. Patient Educ Couns. 2002;47:77–82.PubMedCrossRefGoogle Scholar
  28. 28.
    Fritsch MA, Lamp KC. Low pharmacist counselling rates in the Kansas city, Missouri, metropolitan area. Ann Pharmacother. 1997;31:984–91.PubMedGoogle Scholar
  29. 29.
    Schommer JC, Wiederholt JB. Pharmacists’ views of patient counselling. Am Pharm. 1994;NS34:46–53.PubMedGoogle Scholar
  30. 30.
    Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients’ perspectives on medication-related problems. Patient Educ Couns. 2006;65:407–15. doi: 10.1016/j.pec.2006.09.012.PubMedCrossRefGoogle Scholar
  31. 31.
    Aslanpour Z, Smith FJ. Oral counselling on dispensed medication: a survey of its extent and associated factors in a random sample of community pharmacies. Int J Pharm Pract. 1997;5:57–63.Google Scholar
  32. 32.
    Blom L, Jonkers R, Kok G, Bakker A. Patient education in 20 Dutch community pharmacies: analysis of audiotaped patient contacts. Int J Pharm Pract. 1998;6:72–6.Google Scholar
  33. 33.
    Hassell K, Noyce PR, Rogers A, Harris J, Wilkinson J. Advice provided in British community pharmacies: what people want and what they get. J Health Serv Res Policy. 1998;3:219–25.PubMedGoogle Scholar
  34. 34.
    Krska J, Kennedy EJ, Milne SA, McKessack KJ. Frequency of counselling on prescription medicines in community pharmacy. Int J Pharm Pract. 1995;3:178–85.Google Scholar
  35. 35.
    Svarstad BL, Bultman DC, Mount JK. Patient counselling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44:22–9.CrossRefGoogle Scholar
  36. 36.
    Schmidt LE, Dalhoff K. Food–drug interactions. Drugs. 2002;62:1481–502.PubMedCrossRefGoogle Scholar
  37. 37.
    Roller L, Gowan J. Acne and depression: an important referral and counselling role for pharmacists. Aust J Pharm. 2005;86:750–4.Google Scholar
  38. 38.
    Beest FJ, Koerselman J, Herings RM. Quantity and quality of potential drug interactions with coumarin anticoagulants in the Netherlands. Pharm World Sci. 2007;29:671–5. doi: 10.1007/s11096-007-9127-x.CrossRefGoogle Scholar
  39. 39.
    Pletz MW, Preechachatchaval V, Bulitta J, Allewelt M, Burkhardt O, Lode H. ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate. Antimicrob Agents Chemother. 2003;47:1129–31. doi: 10.1128/AAC.47.3.1129-1131.2003.PubMedCrossRefGoogle Scholar
  40. 40.
    O’Connor-Semmes RL, Kersey K, Williams DH, Lam R, Koch KM. Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19–60 years) and older (61–78 years) people. Clin Pharmacol Ther. 2001;70:126–31. doi: 10.1067/mcp.2001.117120.PubMedCrossRefGoogle Scholar
  41. 41.
    Vainio KK, Airaksinen MSA, Hyykky TT, Enlund KH. Effect of therapeutic class on counselling in community pharmacies. Ann Pharmacother. 2002;36:781–6. doi: 10.1345/aph.1A374.PubMedCrossRefGoogle Scholar
  42. 42.
    Sklubalova Z, Zatloukal Z. Study of eye drops dispensing and dose variability by using plastic dropper tips. Drug Dev Ind Pharm. 2006;32:197–205. doi: 10.1080/03639040500466130.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Hanni Prihhastuti Puspitasari
    • 1
    Email author
  • Parisa Aslani
    • 1
  • Ines Krass
    • 1
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia

Personalised recommendations